Aptose Biosciences Inc (NASDAQ:APTO) has a beta value of 0.87 and has seen 0.5 million shares traded in the recent trading session. The company, currently valued at $10.30M, closed the recent trade at $0.17 per share which meant it lost -$0.02 on the day or -10.74% during that session. The APTO stock price is -1194.12% off its 52-week high price of $2.20 and 23.53% above the 52-week low of $0.13. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.48 million shares traded. The 3-month trading volume is 6.84 million shares.
The consensus among analysts is that Aptose Biosciences Inc (APTO) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.35.
Aptose Biosciences Inc (NASDAQ:APTO) trade information
Sporting -10.74% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the APTO stock price touched $0.17 or saw a rise of 23.9%. Year-to-date, Aptose Biosciences Inc shares have moved -24.01%, while the 5-day performance has seen it change -18.05%. Over the past 30 days, the shares of Aptose Biosciences Inc (NASDAQ:APTO) have changed -31.71%. Short interest in the company has seen 1.31 million shares shorted with days to cover at 0.07.
Aptose Biosciences Inc (APTO) estimates and forecasts
Figures show that Aptose Biosciences Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -69.81% over the past 6 months, with this year growth rate of 76.39%, compared to 16.20% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 10.18% over the past 5 years.
APTO Dividends
Aptose Biosciences Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
Insiders own 6.10% of the company shares, while shares held by institutions stand at 5.41% with a share float percentage of 5.76%. Investors are also buoyed by the number of investors in a company, with Aptose Biosciences Inc having a total of 30.0 institutions that hold shares in the company. The top two institutional holders are DOHENY ASSET MANAGEMENT /CA with over 50550.0 shares worth more than $0.32 million. As of 2024-06-30, DOHENY ASSET MANAGEMENT /CA held 0.3849% of shares outstanding.
The other major institutional holder is CALDWELL SUTTER CAPITAL, INC., with the holding of over 92.0 shares as of 2024-06-30. The firm’s total holdings are worth over $70.0 and represent 0.0007% of shares outstanding.
